Showing results (31-40 of 611) with videos related to
Sort By:
Pageof 62
Journal Des Maladies Vasculaires|January 1, 1987
[Biological modifications induced by 3 low molecular weight heparins, PK 10169, Kabi 2165 and CY 216, compared to unfractionated heparin injected subcutaneously in healthy subjects in general surgery and in aged subjects in internal medicine]L Bara, S Combe-Tamzali, J Conard, et al.Annals of Medicine|February 24, 2001
Heparin-induced thrombocytopenia: laboratory diagnosis and managementI Elalamy, C Lecrubier, M H Horellou, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|July 20, 1999
[Hereditary resistance to vitamin K antagonists. Apropos of a case]F Paganelli, J Conard, R Gelisse, et al.Journal Des Maladies Vasculaires|January 1, 1995
[Hemorrhagic complications of anti-vitamin K treatments]S Bentolila, S Radenne, M H Horellou, et al.Haemostasis|January 1, 1987
Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest)L Bara, S Combe-Tamzali, J Conard, et al.Journal Des Maladies Vasculaires|January 1, 1987
[Platelet aggregation tests in 26 cases of heparin-induced thrombopenia. Methodological, diagnostic problems and therapeutic aspects]C Lecrubier, T Lecompte, F Potevin, et al.International Angiology : a Journal of the International Union of Angiology|May 22, 2004
Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episodeE Ombandza-Moussa, M M Samama, M H Horellou, et al.Blood|August 1, 1988
Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosisG Nguyen, M H Horellou, E K Kruithof, et al.Presse Medicale (Paris, France : 1983)|June 14, 1997
[Multigenic thrombophilia: genetic anomaly of factor II and mutation of factor V Leiden. Study in a French family]J Conard, C Mabileau-Brouzes, M H Horellou, et al.Annales De Biologie Clinique|January 1, 1983
[Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results]J Bogaty-Yver, J J Musitelli, J Conard, et al.Pageof 62